Cognition, reserve, and amyloid deposition in normal aging

Annals of Neurology

Volumn 67, Issue 3, 2010, Pages 353-364

  Rentz, Dorene M ^a   Locascio, Joseph J ^a,b   Becker, John A ^a   Moran, Erin K ^a   Eng, Elisha ^a   Buckner, Randy L ^a,c,d   Sperling, Reisa A ^a   Johnson, Keith A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c HARVARD UNIVERSITY   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CARBON 11; PITTSBURGH COMPOUND B C 11; TRACER; UNCLASSIFIED DRUG;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DEPTH PERCEPTION; FEMALE; FRONTAL LOBE; GERIATRIC DEPRESSION SCALE; HUMAN; INTELLIGENCE QUOTIENT; LANGUAGE; MALE; MINI MENTAL STATE EXAMINATION; MULTIPLE REGRESSION; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; OCCIPITAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TASK PERFORMANCE; WORKING MEMORY;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; BENZOTHIAZOLES; COGNITION; COGNITION DISORDERS; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; SENILE PLAQUES; SEVERITY OF ILLNESS INDEX;

EID: 77950538370     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21904     Document Type: Article

References (73)

1. Arriagada PV, Growdon JH, Hedley-White ET, et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-639.
2. Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimertype pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 1992;42: 1681-1688.
3. Duyckaerts C, Colle MA, Dessi F, et al. Progression of Alzheimer histopathological changes. Acta Neurol Belg 1998;98:180-185.
4. Giannakopoulos P, Herrmann FR, Bussiere T, et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 2003;60:1495-1500. (Pubitemid 36559525)
5. Ingelsson M, Fukumoto H, Newell KL, et al. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 2004;62:925-931. (Pubitemid 38435780)
6. Nagy Z, Esiri MM, Jobst KA, et al. Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia 1995;6:21-31.
7. Edison P, Archer HA, Hinz R, et al. Amyloid, hypometabolism, and cognition in Alzheimer disease. An [11C]PIB and [18F]FDG PET study. Neurology 2007;68:501-508.
8. Engler H, Forsberg A, Almkvist O, et al. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain 2006;129:2856-2866. (Pubitemid 44684508)
9. Johnson KA, Gregas M, Becker JA, et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol 2007;62:229-234. (Pubitemid 47525398)
10. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004;55:306-319. (Pubitemid 38269583)
11. Rowe CC, Ng S, Ackermann U, et al. Imaging beta-amyloid burden in aging and dementia. Neurology 2007;68:1718-1725. (Pubitemid 46763260)
12. Bacskai BJ, Frosch MP, Freeman SH, et al. Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol 2007;64:431-434. (Pubitemid 46425701)
13. Gomperts SN, Rentz DM, Moran E, et al. Imaging amyloid deposition in Lewy body diseases. Neurology 2008;71:903-910.
14. Greenberg SM, Grabowski T, Gurol ME, et al. Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B. Ann Neurol 2008;64:587-591.
15. Forsberg A, Engler H, Almkvist O, et al. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging 2008;29:1456-1465.
16. Pike KE, Savage G, Villemagne VL, et al. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain 2007;130:2837-2844. (Pubitemid 350033975)
17. Buckner RL, Snyder AZ, Shannon BJ, et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 2005;25:7709-7717.
18. Aizenstein HJ, Nebes RD, Saxton JA, et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 2008;65:1509-1517.
19. Mintun MA, Larossa GN, Sheline YI, et al. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006;67:446-452.
20. Jack CR Jr, Lowe VJ, Senjem ML, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 2008;131:665-680.
21. Dickerson BC, Bakkour A, Salat DH, et al. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 2009;19:497-510.
22. Fotenos AF, Mintun MA, Snyder AZ, et al. Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve. Arch Neurol 2008;65:113-120.
23. Sperling RA, Laviolette PS, O'Keefe K, et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 2009;63:178-188.
24. Katzman R, Anderson JM, Fuld P, et al. Development of dementing illness in an 80-year-old volunteer cohort. Ann Neurol 1989;25:317-324.
25. van Praag H, Christie BR, Sejnowski TJ, et al. Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc Natl Acad Sci U S A 1999;96:13427-13431.
26. Cabeza R, Anderson ND, Locantore JK, et al. Aging gracefully: compensatory brain activity in high-performing older adults. Neuroimage 2002;17:1394-1402. (Pubitemid 35339393)
27. Scarmeas N, Zarahn E, Anderson KE, et al. Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects. Neuroimage 2003;19:1215-1227. (Pubitemid 36918257)
28. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002;8:448-460. (Pubitemid 34296102)
29. Bennett DA, Wilson RS, Schneider JA, et al. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 2003;60:1909-1915. (Pubitemid 36736005)
30. Katzman R, Terry R, DeTeresa R, et al. Clinical, pathological, and neurobiological changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 1988;23:138-144.
31. Bennett DA, Schneider JA, Arvanitakis Z, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006;66:1837-1844. (Pubitemid 44049813)
32. Stern Y, Alexander GE, Prohovnik I, et al. Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Ann Neurol 1992;32:371-375.
33. Stern Y, Gurlad BJ, Tatemichi T, et al. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 1994;271:1004-1010. (Pubitemid 24099921)
34. Stern Y, Tang MX, Denaro J, et al. Increased risk of mortality in Alzheimer's disease patients with more advanced educational and occupational attainment. Ann Neurol 1995;37:590-595.
35. Stern Y, Albert S, Tang MX, et al. Rate of memory decline in AD is related to education and occupation. Neurology 1999;53:1942-1947.
36. Roe CM, Mintun MA, D'Angelo G, et al. Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake. Arch Neurol 2008;65:1467-1471.
37. Kemppainen NM, Aalto S, Karrasch M, et al. Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease. Ann Neurol 2008;63:112-118.
38. Morris JC. The Clinical Dementia Rating Scale (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
39. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
40. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale. J Psychiatr Res 1983;17:37-49.
41. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
42. Wechsler D. WAIS-III, Wechsler Adult Intelligence Scale - third edition, administration and scoring manual. New York, NY: The Psychological Corporation, 1997.
43. Reitan R. Manual for administration of neuropsychological test batteries for adults and children. Tuscon, AZ: Reitan Neuropsychology Laboratories, 1979.
44. Benton AL, Varney NR, Hamsher KD, et al. Contributions to neuropsychological assessment. Oxford, UK: Oxford University Press, 1983.
45. Monsch AU, Bondi MW, Butters N, et al. Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer's type. Arch Neurol 1992;49:1253-1258.
46. Grober E, Lipton RB, Hall C, et al. Memory impairment on free and cued selective reminding predicts dementia. Neurology 2000;54:827-832. (Pubitemid 30111337)
47. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test: assessment of aphasia and related disorders. 2nd ed. Philadelphia, PA: Lea & Febiger, 1983.
48. Ryan J, Paolo A. A screening procedure for estimating premorbid intelligence in the elderly. Clin Neuropsychol 1992;6:53-62.
49. Friedman RB, Ferguson S, Robinson S, et al. Dissociation of mechanisms of reading in Alzheimer's disease. Brain Lang 1992; 43:400-413.
50. Nelson HE, O'Connell A. Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex 1978;14:234-244.
51. Wiens AN, Bryan JE, Crossen JR. Estimating WAIS-R FSIQ from National Adult Reading Test-Revised in normal subjects. Clin Neuropsychol 1993;7:70-84.
52. Alexander GE, Furey ML, Grady CL, et al. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis. Am J Psychiatry 1997;154:165-172.
53. O'Carroll RE, Prentice N, Murray C, et al. Further evidence that reading ability is not preserved in Alzheimer's disease. Br J Psychiatry 1995;167:659-662. (Pubitemid 26197778)
54. Schmand B, Geerlings M, Jonker C, et al. Reading ability as an estimator of premorbid intelligence: does it remain stable in emergent dementia? J Clin Exp Neuropsychol 1998;20:42-51.
55. Mathis CA, Wang Y, Holt DP, et al. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem 2003;46:2740-2754. (Pubitemid 36702542)
56. Logan J, Fowler JS, Volkow ND, et al. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996;16:834-840. (Pubitemid 26292051)
57. Price JC, Klunk WE, Lopresti BJ, et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab 2005;25:1528-1547.
58. Archer HA, Edison P, Brooks DJ, et al. Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study. Ann Neurol 2006;60:145-147.
59. Fagan AM, Mintun MA, Mach RH, et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta(42) in humans. Ann Neurol 2006;59:512-519.
60. Lopresti BJ, Klunk WE, Mathis CA, et al. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med 2005;46:1959-1972.
61. Rabinovici GD, Furst AJ, O'neil JP, et al. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology 2007;68:1205-1212.
62. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273-289.
63. Cohen JCP, West SGALS. Applied multiple regression/correlation analysis for the behavioral sciences. 3rd ed. Mahwah, NJ: Lawrence Erlbaum Associates, 2003.
64. Mormino EC, Kluth JT, Madison CM, et al. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain 2009;132:1310-1323.
65. Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 2004;44:181-193. (Pubitemid 39348839)
66. Shankar GM, Li S, Mehta TH, et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 2008;14:837-842.
67. Stern Y, Habeck C, Moeller J, et al. Brain networks associated with cognitive reserve in healthy young and old adults. Cereb Cortex 2005;15:394-402. (Pubitemid 40388240)
68. Stern Y, Zarahn E, Habeck C, et al. A common neural network for cognitive reserve in verbal and object working memory in young but not old. Cereb Cortex 2008;18:959-967.
69. Butters N, Granholm E, Salmon DP, et al. Episodic and semantic memory: a comparison of amnesic and demented patients. J Clin Exp Neuropsychol 1987;9:479-497.
70. Taylor KI, Salmon DP, Monsch AU, et al. Semantic and phonemic sequence effects in random word generation: a dissociation between Alzheimer's and Huntington's disease patients. J Int Neuropsychol Soc 2005;11:303-310.
71. Scarmeas N, Zarahn E, Anderson KE, et al. Association of life activities with cerebral blood .ow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol 2003;60:359-365. (Pubitemid 36314361)
72. Rentz DM, Huh TJ, Faust RF, et al. Use of IQ adjusted norms to predict progressive cognitive decline in highly intelligent older individuals. Neuropsychology 2004;18:38-49.
73. Reiman EM, Chen K, Liu X, et al. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA 2009;106:6820-6825.